FDA, CDC and CMS launch task force to provide diagnostic tests during public health emergencies
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC) and the Centers for Medicare…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Mar 19
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC) and the Centers for Medicare…
28 Feb 19
The FDA has granted T2 Biosystems, Inc. (NASDAQ:TTOO) “Breakthrough Device” designation for the T2Resistance Panel, a diagnostic panel…
27 Feb 19
Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia have developed a…
26 Feb 19
Mobidiag, a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, has signed multiple exclusive agreements…
22 Feb 19
The days – or even weeks – spent waiting for the results of a cancer-screening test can feel…
21 Feb 19
Healthcare firm Abbott has secured CE mark approval for Determine HBsAg 2, which is claimed to be the…
15 Feb 19
Miami Cancer Institute, part of Baptist Health South Florida, has implemented Philips’ IntelliSpace Precision Medicine Genomics in its…
15 Feb 19
New research from scientists at the Medical Research Council (MRC) Toxicology Unit and University of Leicester has suggested…
15 Feb 19
Medical technology company Hologic has received two new CE marks in Europe for its Aptima HIV-1 Quant Dx…
13 Feb 19
ANGLE has announced that its Parsortix system has been utilized in further ground-breaking cancer research into CTC clusters…